AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study

Exclusion Criteria

• •Irregular astigmatism (e.g. keratoconus)
• •Corneal pathology (e.g. scar, dystrophy, pterygium, moderate-to-severe dry eye)
• •Monocular status (e.g. amblyopia)
• •Previous radial keratotomy, corneal refractive surgery or other corneal surgery (e.g. corneal transplant, lamellar keratoplasty)
• •Previous anterior or posterior chamber surgery (e.g., vitrectomy, laser iridotomy)
• •Diabetic retinopathy
• •Macular pathology (e.g. age-related macular degeneration, epiretinal membrane)
• •History of retinal detachment
• •Subjects who have an acute or chronic disease or illness that would confound the results of this investigation (e.g., immunocompromised, connective tissue disease, clinically significant atopic disease, diabetes, and any other such disease or illness), that are known to affect postoperative visual acuity.
• •Participation in (or current participation) any investigational drug or device trial within the previous 30 days prior to the start date of this trial.
• •The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
• •Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.